Nifty
Sensex
:
:
18634.05
62919.10
35.40 (0.19%)
72.72 (0.12%)

Pharmaceuticals & Drugs - Domestic

Rating :
48/99

BSE: 531349 | NSE: PANACEABIO

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 750.93
  • 0.62
  • 1
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 201.81
  • N/A
  • 0.91

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 73.59%
  • 8.80%
  • 15.82%
  • FII
  • DII
  • Others
  • 0.18%
  • 0.00%
  • 1.61%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 0.83
  • 2.21
  • 6.72

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -16.68
  • -
  • -

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -8.61
  • 5.42
  • -15.13

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • -

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -3.70
  • 3.36
  • 6.31

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 0.89
  • -10.13
  • -19.44

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Dec 22
Dec 21
Var%
Sep 22
Sep 21
Var%
Jun 22
Jun 21
Var%
Mar 22
Mar 21
Var%
Net Sales
115.20
155.88
-26.10%
105.12
232.17
-54.72%
110.70
132.45
-16.42%
140.73
168.27
-16.37%
Expenses
123.84
144.02
-14.01%
108.96
226.15
-51.82%
190.51
134.00
42.17%
170.92
167.33
2.15%
EBITDA
-8.64
11.86
-
-3.84
6.02
-
-79.81
-1.55
-
-30.19
0.94
-
EBIDTM
-7.50%
7.61%
-3.65%
2.59%
-72.10%
-1.17%
-21.45%
0.56%
Other Income
13.94
1.66
739.76%
10.45
2.03
414.78%
12.21
3.23
278.02%
4.05
4.90
-17.35%
Interest
0.96
52.13
-98.16%
1.18
50.16
-97.65%
1.25
47.89
-97.39%
30.66
46.91
-34.64%
Depreciation
9.67
10.55
-8.34%
9.89
10.90
-9.27%
10.05
11.06
-9.13%
11.15
11.58
-3.71%
PBT
22.44
-49.16
-
23.31
-53.01
-
-51.16
-57.27
-
1,608.26
-52.65
-
Tax
3.07
0.04
7,575.00%
7.61
0.00
0
4.98
0.08
6,125.00%
370.79
1.49
24,785.23%
PAT
19.37
-49.20
-
15.70
-53.01
-
-56.14
-57.35
-
1,237.47
-54.14
-
PATM
16.81%
-31.56%
14.94%
-22.83%
-50.71%
-43.30%
879.32%
-32.17%
EPS
3.16
-8.03
-
2.56
-8.65
-
-9.16
-9.36
-
201.87
-8.83
-

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Net Sales
471.75
661.23
624.80
544.06
456.70
592.79
544.01
653.08
687.19
509.99
608.49
Net Sales Growth
-31.51%
5.83%
14.84%
19.13%
-22.96%
8.97%
-16.70%
-4.96%
34.75%
-16.19%
 
Cost Of Goods Sold
264.28
262.20
204.63
156.79
172.24
187.25
149.52
215.81
280.21
214.00
263.41
Gross Profit
207.47
399.02
420.17
387.27
284.45
405.55
394.50
437.27
406.98
295.99
345.08
GP Margin
43.98%
60.35%
67.25%
71.18%
62.28%
68.41%
72.52%
66.96%
59.22%
58.04%
56.71%
Total Expenditure
594.23
675.10
548.18
518.57
589.83
508.26
496.89
541.37
643.31
592.00
694.55
Power & Fuel Cost
-
37.82
30.94
29.74
34.55
33.52
30.55
25.15
30.73
31.74
37.76
% Of Sales
-
5.72%
4.95%
5.47%
7.57%
5.65%
5.62%
3.85%
4.47%
6.22%
6.21%
Employee Cost
-
182.94
156.17
144.42
147.08
151.59
148.12
142.02
135.98
144.92
146.94
% Of Sales
-
27.67%
25.00%
26.54%
32.20%
25.57%
27.23%
21.75%
19.79%
28.42%
24.15%
Manufacturing Exp.
-
78.70
43.22
33.38
44.31
40.05
41.88
39.47
43.97
52.69
67.15
% Of Sales
-
11.90%
6.92%
6.14%
9.70%
6.76%
7.70%
6.04%
6.40%
10.33%
11.04%
General & Admin Exp.
-
53.34
47.48
54.20
71.07
40.39
52.98
39.41
56.82
60.39
73.47
% Of Sales
-
8.07%
7.60%
9.96%
15.56%
6.81%
9.74%
6.03%
8.27%
11.84%
12.07%
Selling & Distn. Exp.
-
48.08
51.18
42.81
31.27
36.98
37.70
44.20
44.20
46.09
48.87
% Of Sales
-
7.27%
8.19%
7.87%
6.85%
6.24%
6.93%
6.77%
6.43%
9.04%
8.03%
Miscellaneous Exp.
-
12.00
14.56
57.24
89.31
18.48
36.14
35.31
51.40
42.17
48.87
% Of Sales
-
1.81%
2.33%
10.52%
19.56%
3.12%
6.64%
5.41%
7.48%
8.27%
9.36%
EBITDA
-122.48
-13.87
76.62
25.49
-133.13
84.53
47.12
111.71
43.88
-82.01
-86.06
EBITDA Margin
-25.96%
-2.10%
12.26%
4.69%
-29.15%
14.26%
8.66%
17.11%
6.39%
-16.08%
-14.14%
Other Income
40.65
10.97
9.98
30.35
5.06
8.23
46.59
20.35
28.48
15.36
5.44
Interest
34.05
180.84
185.34
173.98
104.83
100.58
100.93
127.33
104.53
150.30
103.76
Depreciation
40.76
43.66
45.59
44.13
55.03
58.53
67.95
73.32
67.24
71.10
85.99
PBT
1,602.85
-227.40
-144.32
-162.28
-287.93
-66.35
-75.17
-68.59
-99.41
-288.05
-270.37
Tax
386.45
370.90
1.96
16.95
8.56
9.86
-10.98
1.92
3.08
1.68
-18.76
Tax Rate
24.11%
25.60%
-1.36%
-9.54%
18.58%
-14.86%
16.28%
-10.14%
-3.10%
-1.51%
7.41%
PAT
1,216.40
1,077.88
-146.24
-194.60
37.58
-74.18
-54.75
-18.51
-100.70
-111.56
-234.30
PAT before Minority Interest
1,216.40
1,077.90
-146.20
-194.63
37.52
-76.20
-56.47
-20.85
-102.49
-112.64
-234.30
Minority Interest
0.00
-0.02
-0.04
0.03
0.06
2.02
1.72
2.34
1.79
1.08
0.00
PAT Margin
257.85%
163.01%
-23.41%
-35.77%
8.23%
-12.51%
-10.06%
-2.83%
-14.65%
-21.87%
-38.51%
PAT Growth
669.21%
-
-
-
-
-
-
-
-
-
 
EPS
198.43
175.84
-23.86
-31.75
6.13
-12.10
-8.93
-3.02
-16.43
-18.20
-38.22

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Shareholder's Funds
848.79
-228.69
198.79
350.40
308.68
355.68
448.61
471.29
512.72
625.69
Share Capital
6.13
6.13
6.13
6.13
6.13
6.13
22.43
22.43
6.13
6.13
Total Reserves
842.67
-234.82
160.66
344.27
302.55
349.55
426.18
448.76
506.59
619.56
Non-Current Liabilities
103.75
959.99
740.66
70.08
591.13
718.78
1,100.11
918.47
767.07
865.20
Secured Loans
0.24
675.05
583.55
8.90
560.45
704.57
866.08
721.77
581.77
688.31
Unsecured Loans
33.87
60.03
29.58
37.22
10.26
9.49
1.00
1.20
1.40
1.60
Long Term Provisions
29.23
30.65
42.74
39.78
26.54
18.36
184.42
180.43
180.47
171.27
Current Liabilities
802.77
449.09
622.14
938.26
695.52
689.13
474.80
706.03
826.82
509.96
Trade Payables
259.78
246.66
198.85
269.71
277.19
248.60
187.87
209.13
252.11
175.69
Other Current Liabilities
530.52
189.06
242.12
585.25
242.00
237.52
93.60
194.85
251.91
49.82
Short Term Borrowings
0.00
0.00
3.57
69.39
164.88
190.71
191.82
295.84
320.67
274.00
Short Term Provisions
12.47
13.37
177.60
13.92
11.44
12.30
1.51
6.21
2.13
10.45
Total Liabilities
1,752.33
1,177.39
1,558.55
1,355.73
1,592.38
1,774.13
2,024.60
2,099.21
2,112.09
2,008.20
Net Block
589.28
608.70
657.39
805.56
948.97
1,001.37
1,071.11
1,144.30
1,275.54
1,154.49
Gross Block
1,284.46
1,266.39
1,282.22
1,392.90
1,605.84
1,600.07
1,620.29
1,633.48
1,697.63
1,694.13
Accumulated Depreciation
695.18
657.69
624.84
587.34
656.87
598.70
549.18
489.18
422.09
539.64
Non Current Assets
711.78
666.41
875.27
847.84
1,027.55
1,070.91
1,475.22
1,573.49
1,739.28
1,574.45
Capital Work in Progress
17.26
34.42
24.01
22.51
39.92
30.41
115.78
110.31
116.55
135.26
Non Current Investment
0.07
0.07
5.58
5.33
5.25
7.01
5.19
10.20
15.97
16.51
Long Term Loans & Adv.
21.46
17.62
187.70
13.33
28.01
22.03
236.71
262.44
274.94
266.34
Other Non Current Assets
83.71
5.61
0.60
1.12
5.39
10.09
1.26
1.07
0.35
1.85
Current Assets
1,040.55
510.97
683.27
507.89
564.83
703.22
549.38
525.72
372.81
433.75
Current Investments
5.00
0.00
0.00
0.00
2.03
0.27
3.52
4.98
0.00
5.99
Inventories
212.72
174.14
147.69
81.43
334.21
315.55
305.24
310.22
219.81
267.94
Sundry Debtors
131.66
84.68
68.52
88.73
136.01
142.17
141.67
98.57
94.93
69.86
Cash & Bank
583.28
135.79
89.75
23.48
23.24
14.13
22.93
52.40
24.78
39.23
Other Current Assets
107.89
52.64
335.69
273.23
69.36
231.09
76.02
59.55
33.29
50.73
Short Term Loans & Adv.
59.15
63.72
41.62
41.02
59.30
56.21
66.76
50.15
24.72
44.44
Net Current Assets
237.78
61.88
61.13
-430.38
-130.69
14.08
74.58
-180.31
-454.01
-76.21
Total Assets
1,752.33
1,177.38
1,558.54
1,355.73
1,592.38
1,774.13
2,024.60
2,099.21
2,112.09
2,008.20

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Cash From Operating Activity
-108.44
106.76
-30.47
104.80
118.02
130.67
90.69
37.23
53.73
-24.02
PBT
1,448.81
-145.03
-177.34
46.23
-66.14
-67.18
-18.93
-99.41
-110.96
-253.06
Adjustment
-1,455.07
230.88
253.04
-70.58
166.62
149.57
148.75
167.45
59.92
161.18
Changes in Working Capital
301.53
21.91
-97.50
127.32
21.45
43.32
-58.26
-25.16
107.22
68.23
Cash after chg. in Working capital
295.26
107.76
-21.80
102.97
121.93
125.71
71.56
42.88
56.18
-23.65
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-403.70
-1.00
-8.67
1.83
-3.91
4.96
19.13
-5.65
-2.45
-0.37
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
1,282.57
-47.68
-34.76
-5.27
55.29
-25.83
16.44
-37.38
-37.60
-61.19
Net Fixed Assets
-26.71
28.01
223.59
488.74
-15.06
-27.48
11.93
-29.48
-5.26
-31.39
Net Investments
0.00
54.26
-51.99
342.34
0.00
49.78
0.00
-0.46
-122.35
-13.38
Others
1,309.28
-129.95
-206.36
-836.35
70.35
-48.13
4.51
-7.44
90.01
-16.42
Cash from Financing Activity
-1,175.85
-47.11
90.74
-101.14
-164.35
-106.96
-117.38
-0.70
-30.26
104.89
Net Cash Inflow / Outflow
-1.72
11.97
25.51
-1.61
8.97
-2.13
-10.25
-0.85
-14.13
19.68
Opening Cash & Equivalents
52.08
40.22
14.47
16.44
7.47
9.59
19.97
20.84
34.95
15.16
Closing Cash & Equivalent
50.35
52.08
40.22
14.47
16.44
7.47
9.73
19.99
20.84
34.95

Financial Ratios

Consolidated /

Standalone
Description
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Book Value (Rs.)
138.58
-37.34
27.23
57.21
50.40
58.07
-4.43
-0.75
13.96
34.08
ROA
73.58%
-10.69%
-13.36%
2.55%
-4.53%
-2.97%
-1.01%
-4.87%
-5.47%
-11.36%
ROE
347.66%
0.00%
-75.26%
11.39%
-22.94%
-34.38%
0.00%
-253.03%
-76.49%
-71.43%
ROCE
221.15%
5.36%
-0.38%
13.44%
2.63%
2.76%
9.93%
0.45%
3.37%
-11.89%
Fixed Asset Turnover
0.55
0.51
0.41
0.30
0.37
0.35
0.40
0.41
0.30
0.37
Receivable days
56.79
42.68
52.75
89.81
85.16
92.84
67.10
51.36
58.89
41.39
Inventory Days
101.55
89.66
76.86
166.09
198.91
203.06
171.89
140.68
174.32
195.55
Payable days
352.48
397.33
178.20
213.56
186.55
163.89
130.73
137.37
148.94
82.64
Cash Conversion Cycle
-194.15
-264.98
-48.60
42.34
97.52
132.00
108.26
54.67
84.27
154.30
Total Debt/Equity
0.04
-3.58
4.45
1.85
3.05
2.79
-100.22
93.42
12.38
4.69
Interest Cover
9.01
0.22
-0.02
1.44
0.34
0.33
0.85
0.05
0.26
-1.44

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.